Joseph J. Pirrello III

Joseph J. Pirrello III has a strong background in business development and strategy. Joseph J. has most recently served as the Chief Business Officer at Kiniksa Pharmaceuticals since November 2022. Prior to this role, Joseph worked as the Executive Director, Head of Business Development at Astria Therapeutics, Inc. from August 2021 to November 2022.

Before joining Astria Therapeutics, Joseph held various roles at Kiniksa Pharmaceuticals. These roles included Director, Business Development & New Product Strategy from July 2020 to August 2021, Associate Director, Business Development from April 2019 to July 2020, Senior Manager, Business Development from June 2017 to April 2019, and Manager, Business Development from March 2016 to June 2017.

Joseph also gained experience as a Senior Consultant and Consultant at Navigant from March 2015 to March 2016 and from January 2014 to March 2015, respectively. Prior to Navigant, they worked as a Summer Associate at Navigant in 2013 and as a Research and Development Intern at SpringLeaf Therapeutics in 2012.

Earlier in their career, Joseph worked as a Student Advisor Coordinator at Boston University from May 2011 to May 2012. Joseph J. also served as an Assistant Site Leader at Fort Lee Recreation, where they managed and oversaw a large group of children and counselors during the summer months of 2010 and 2011.

Overall, Joseph J. Pirrello III has a diverse professional background, with a focus on business development and strategy in the pharmaceutical industry.

Joseph J. Pirrello III completed their Bachelor of Science degree in Biomedical/Medical Engineering from Boston University, where they studied from 2008 to 2012. Joseph J. later pursued their Master of Engineering Management (M.E.M.) degree at Dartmouth College's Thayer School of Engineering from 2012 to 2013.